Seeing Is Believing
Healthcare - Sector
FOLD is currently covered by 8 analysts with an average price target of $18.96. This is a potential upside of $4.63 (32.31%) from yesterday's end of day stock price of $14.33.
Amicus Therapeutics's activity chart (see below) currently has 165 price targets and 116 ratings on display. The stock rating distribution of FOLD is 45.45% BUY and 54.55% HOLD.
Analysts average stock forecasts to be materialized ratio is 53.96% with an average time for these price targets to be met of 366.84 days.
Highest price target for FOLD is $19, Lowest price target is $9, average price target is $14.3.
Most recent stock forecast was given by DENNIS DING from JEFFERIES on 22-Jan-2026. First documented stock forecast 20-Aug-2014.
Currently out of the existing stock ratings of FOLD, 5 are a BUY (45.45%), 6 are a HOLD (54.55%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 22-Jan-2026
$14.5
$0.13 (0.90%)
$18
1 months 12 days ago
(22-Jan-2026)
0/2 (0%)
$0.23 (1.61%)
Hold Since 29-Dec-2025
$14.5
$0.13 (0.90%)
$14
2 months 5 days ago
(29-Dec-2025)
6/10 (60%)
$0.25 (1.75%)
465
Hold Since 19-Dec-2025
$14.5
$0.13 (0.90%)
$21
2 months 15 days ago
(19-Dec-2025)
0/8 (0%)
$0.32 (2.26%)
Hold Since 19-Dec-2025
$14
2 months 15 days ago
(19-Dec-2025)
1/1 (100%)
$5.52 (65.09%)
92
Buy Since 23-Feb-2016
$19
$4.63 (32.22%)
$16
4 months ago
(06-Nov-2025)
6/17 (35.29%)
$10.1 (113.48%)
454
What is FOLD (Amicus Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on FOLD (Amicus Therapeutics) with a proven track record?
Which analyst has the most public recommendations on FOLD (Amicus Therapeutics)?
Which analyst is the currently most bullish on FOLD (Amicus Therapeutics)?
Which analyst is the currently most reserved on FOLD (Amicus Therapeutics)?